![RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study - Annals of Oncology RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/91800d40-9ba5-413e-ba9c-e823c67a002f/gr1.jpg)
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study - Annals of Oncology
![Computational advances of tumor marker selection and sample classification in cancer proteomics - ScienceDirect Computational advances of tumor marker selection and sample classification in cancer proteomics - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S200103702030341X-ga1.jpg)
Computational advances of tumor marker selection and sample classification in cancer proteomics - ScienceDirect
![Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy. - Abstract - Europe PMC Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy. - Abstract - Europe PMC](https://europepmc.org/articles/PMC9126915/bin/41467_2022_30063_Fig1_HTML.jpg)
Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy. - Abstract - Europe PMC
![Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer | Journal of Nanobiotechnology | Full Text Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer | Journal of Nanobiotechnology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12951-020-00680-9/MediaObjects/12951_2020_680_Fig1_HTML.png)